Information de reference pour ce titreAccession Number: | 01451459-199809000-00014.
|
Author: | Abadi, Jacobo; Friedman, Joseph; Mageed, Rizgar A.; Jefferis, Roy; Rodriguez-Barradas, Maria C.; Pirofski, Liise-anne
|
Institution: | Departments of Microbiology and Immunology and Medicine, Division of Infectious Diseases, Albert Einstein College of Medicine, Bronx, New York; the Department of Immunology, The Medical School, Edgbaston, Birmingham, United Kingdom; the Kennedy Institute of Rheumatology, London, United Kingdom; and the Houston Veterans Administration Medical Center, Houston, Texas
|
Title: | |
Source: | Journal of Infectious Diseases. 178(3):707-716, September 1998.
|
Abstract: | : Human immunodeficiency virus (HIV)-infected persons manifest decreased antibody responses to pneumococcal polysaccharide vaccines. Since human antibody responses to polysaccharides are often restricted, the molecular structure of antibodies elicited by a 23-valent pneumococcal vaccine was analyzed. Anti-idiotypic reagents were used to detect VH1, VH3, and VH4 gene usage by antibodies to pneumococcal capsular polysaccharides in HIV-uninfected and HIV-infected subjects by ELISA. HIV-uninfected persons generated [beta]-mercaptoethanol-sensitive and -resistant antibodies to pneumococcal capsular polysaccharides expressing VH3 determinants recognized by the D12, 16.84, and B6 monoclonal antibodies; antibodies expressing VH1 determinants were not detected, and VH4 determinants were expressed by [beta]-mercaptoethanol-sensitive antibodies only; and HIV-infected subjects had significantly lower capsular polysaccharide-specific and VH3-positive antibody responses. These findings confirm decreased antibody responses to pneumococcal vaccination in HIV-infected persons and suggest that their poor responses may result from HIV-associated depletion of restricted B cell subsets.
(C) Copyright Oxford University Press 1998.
|
References: | 1. Pirofski L, Casadevall A. The use of licensed vaccines for active immunization of the immunocompromised host. Clin Microb Rev 1998; 11:1-26.
2. Brezinschek HP, Brezinschek RI, Lipsky PE. Analysis of the heavy chain repertoire of human peripheral B cells using single-cell polymerase chain reaction. J Immunol 1995; 155:190-202.
3. Silverman GJ, Lucas AH. Variable region diversity in human circulating antibodies specific for the capsular polysaccharide of Haemophilus influenzae type b. Preferential usage of two types of VH3 heavy chains. J Clin Invest 1991;88:911-20.
4. Pirofski L, Lui R, DeShaw M, et al. Analysis of human monoclonal antibodies elicited by vaccination with a Cryptococcus neoformans glucuronoxylomannan capsular polysaccharide vaccine. Infect Immun 1995;63:3005-14.
5. Shaw DR, Kirkham P, Schroeder HW Jr, et al. Structure-function studies of human monoclonal antibodies to pneumococcus type 3 polysaccharide. Ann NY Acad Sci 1995;764:370-3.
6. Hillson JL, Karr NS, Opliger IR, et al. The structural basis of germlineencoded VH3 immunoglobulin binding to staphylococcal protein A. J Exp Med 1993;178:331-6.
7. Ibrahim S, Seppala IJ, Sarvas H, et al. Proportion of protein A bindable molecules in human IgM and IgA antibodies to seven antigens. Microb Pathog 1993; 15:159-68.
8. Fleuridor R, Jefferis R, Mageed RA, et al. Idiotype expression of antibodies elicited by GXM-TT [abstract E51]. In: Proceedings of the 97th annual meeting of the American Society for Microbiology (Miami Beach, FL). Washington, DC: ASM, 1997.
9. Berberian L, Goodglick L, Kipps TJ, et al. Immunoglobulin VH3 gene products: natural ligands for HIV gp120. Science 1993;261:1588-91.
10. Berberian L, Shukla J, Jefferis R, et al. Effects of HIV infection on VH3 (D12 idiotope) B cells in vivo. J Acquir Immune Defic Syndr 1994;7: 641-6.
11. Lane CH, Masur H, Edgar LC, et al. Abnormalities of B cell activation and immunoregulation in patients with AIDS. N Engl J Med 1993;309: 453-8.
12. Rodriguez-Barradas MC, Musher DM, Lahart C, et al. Antibody to capsular polysaccharides of Streptococcus pneumoniae after vaccination of human immunodeficiency virus-infected subjects with 23-valent pneumococcal vaccine. J Infect Dis 1992; 165:553-6.
13. Carson PJ, Schut RL, Simpson ML, et al. Antibody class and subclass responses to pneumococcal polysaccharides following immunization of human immunodeficiency virus-infected patients. J Infect Dis 1995; 172:340-5.
14. Ahmed F, Steinhoff MC, Rodriguez-Barradas MC, et al. Effect of human immunodeficiency virus type 1 infection on the antibody response to a glycoprotein conjugate pneumococcal vaccine: results from a randomized trial. J Infect Dis 1996; 173:83-90.
15. Rodriguez-Barradas MC, Groover JE, Lacke CE, et al. IgG antibody to pneumococcal capsular polysaccharide in human immunodeficiency virus infected subjects: persistence of antibody in responders, revaccination in nonresponders, and relationship of immunoglobulin allotype to response. J Infect Dis 1996; 173:1347-54.
16. Arpadi SM, Back S, O'Brien J, et al. Antibodies to pneumococcal capsular polysaccharides in children with human immunodeficiency virus infection given polyvalent pneumococcal vaccine. J Pediatr 1994; 125:77-9.
17. Opravil M, Fierz W, Matter L, et al. Poor antibody response after tetanus and pneumococcal vaccination in immunocompromised, HIV-infected patients. Clin Exp Immunol 1991;84:185-9.
18. Unsworth DJ, Rowen D, Came C, et al. Defective IgG2 response to Pneumovax in HIV seropositive patients. Genitourin Med 1993;69: 373-6.
19. Janoff EN, Breiman RF, Daley CL, et al. Pneumococcal disease during HIV infection. Epidemiologic, clinical, and immunologic perspectives. Ann Intern Med 1992;117:314-24.
20. Steele RW, Warrier R, Unkel PJ, et al. Colonization with antibiotic-resistant Streptococcus pneumoniae in children with sickle cell disease. J Pediatr 1996; 128:531-5.
21. Zenni MK, Cheatham SH, Thompson JM, et al. Streptococcus pneumoniae colonization in the young child: association with otitis media and resistance to penicillin. J Pediatr 1995; 127:533-7.
22. Brown EJ, Joiner KA, Cole RM, et al. Localization of complement component 3 on Streptococcus pneumoniae: anti-capsular antibody causes complement deposition on the pneumococcal capsule. Infect Immun 1983;39:403-9.
23. Daar ES, Moudgil T, Meyer RD, et al. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. N Engl J Med 1991;324:961-4.
24. Mageed RA, Moyes SP, Thompson KM, et al. Molecular and cellular aspects of human rheumatoid factor production and idiotypes. In: Shoenfeld Y, Kennedy RC, Ferrone S, eds. Idiotypes in medicine: autoimmunity, infection and cancer. New York: Elsevier Science, 1997:135-55.
25. van Dam JEG, Fleer A, Snippe H. Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides. Antonie van Leeuwenhoek 1990;58:1-47.
26. Dagan R, Melamed R, Muallem M, et al. Nasopharyngeal colonization in southern Israel with antibiotic-resistant pneumococci during the first 2 years of life: relation to serotypes likely to be included in pneumococcal conjugate vaccines. J Infect Dis 1996; 174:1352-5.
27. Mascart-Lemone F, Libin GM, Crusiaux A, et al. Differential effect of human immunodeficiency virus infection on the IgA and IgG antibody responses to pneumococcal vaccine. J Infect Dis 1995; 172:1253-60.
28. Siber GR, Priehs C, Madore D. Standardization of antibody assays for measuring the response to pneumococcal infection and immunization. Pediatr Infect Dis J 1989;8:S84-91.
29. DeShaw M, Pirofski L. Antibodies to Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan are ubiquitous in the serum of HIV+ and HIV- individuals. Clin Exp Immunol 1995;99:425-32.
30. Musher DM. Streptococcus pneumoniae. In: Mandell G, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. New York: Churchill Livingstone, 1995:1811-25.
31. Jefferis R. Idiotypes as markers for immunoglobulin genes contributing to the production of rheumatoid factors: theoretical and practical implications. Clin Exp Rheumatol 1994;12(suppl 11):S71-4.
32. Rassenti LZ, Kohsaka H, Kipps TJ. Analysis of immunoglobulin VH gene repertoire by an anchored PCR-ELISA. Ann NY Acad Sci 1995;764: 463-73.
33. Almagro JC, Dominguez-Martinez V, Lara-Ochoa F, et al. Structural repertoire in human VL pseudogenes of immunoglobulins: comparison with functional germline genes and amino acid sequences. Immunogenetics 1996;43:92-6.
34. Heidelberger M, DiLapi MM, Siegel M, et al. Persistence of antibodies in human subjects injected with pneumococcal polysaccharides. J Immunol 1950;65:535-41.
35. Newkirk MM, Rauch J, Mageed RA, et al. Restricted immunoglobulin variable region gene usage by hybridoma rheumatoid factors from patients with systemic lupus erythematosus and rheumatoid arthritis. Mol Immunol 1993;30:255-63.
36. Suleyman S, Thompson KM, Forre O, et al. Three new cross-reacting idiotopes as markers for the products of two distinct human VH3 genes expressed in the early repertoire. Scand J Immunol 1994;40:681-90.
37. Azmi FH, Lucas AH, Raff HV, et al. Variable region sequences and idiotypic expression of a protective human immunoglobulin M antibody to capsular polysaccharides of Neisseria meningitidis group B and Escherichia coli K1. Infect Immun 1994;62:1776-86.
38. Adderson EE, Shackelford PG, Quinn A, et al. Restricted immunoglobulin VH usage and VDJ combinations in the human response to Haemophilus influenzae type b capsular polysaccharide. Nucleotide sequences of monospecific anti-Haemophilus antibodies and polyspecific antibodies cross-reacting with self antigens. J Clin Invest 1993;91:2734-43.
39. Adderson EE, Shackelford PG, Quinn A, et al. Restricted Ig H chain V gene usage in the human antibody response to Haemophilus influenzae type b capsular polysaccharide. J Immunol 1991; 147:1667-74.
40. Shokri F, Mageed RA, Maziak BR, et al. Expression of VHIII-associated cross-reactive idiotype on human B lymphocytes. Association with staphylococcal protein A binding and Staphylococcus aureus Cowan I stimulation. J Immunol 1991; 146:936-40.
41. Robbins JB, Schneerson R, Glode MP, et al. Cross-reactive antigens and immunity to diseases caused by encapsulated bacteria. J Clin Allergy Immunol 1975;56:1387-98.
42. Lucas AH, Granoff DM, Mandrell RE, et al. Oligoclonality of serum immunoglobulin G antibody responses to Streptococcus pneumoniae capsular polysaccharide serotypes 6B, 14, and 23F. Infect Immun 1997; 65:5103-9.
43. Barington T, Hougs L, Juul L, et al. The progeny of a single virgin B cell predominates the human recall B cell response to the capsular polysaccharide of Haemophilus influenzae type b. J Immunol 1996; 157: 4016-27.
44. Mukherjee J, Casadevall A, Scharff MD. Molecular characterization of the antibody responses to Cryptococcus neoformans infection and glucuronoxylomannan-tetanus toxoid conjugate immunization. J Exp Med 1993;177:1105-16.
45. Deane M, MacKenzie CR, Stevenson FK, et al. The genetic basis of human VH4 gene family-associated cross-reactive idiotype expression in CD5+ and CD5- cord blood B-lymphocyte clones. Scand J Immunol 1993;38:348-58.
46. Potter KN, Capra JD. The cross-reactive idiotypes recognized by monoclonal antibodies 9G4 and Lc1 are located in framework region 1 of two non-overlapping subsets of VH4 family encoded antibodies. Scand J Immunol 1994;40:43-9.
47. Grayzel A, Solomon A, Aranow C, et al. Antibodies elicited by pneumococcal antigens bear an anti-DNA-associated idiotype. J Clin Invest 1991;87:842-6.
48. MacKenzie LE, Youinous PY, Hicks R, et al. Auto and polyreactive IgM from CD5+ and CD5- cord blood B cells. Scand J Immunol 1991;33: 329-35.
49. David D, Demaison C, Bani L, et al. Selective variations in vivo of VH3 and VH1 gene family expression in peripheral B cell IgM, IgD, and IgG during HIV infection. Eur J Immunol 1995;25:1524-8.
50. Jefferis R. Idiotypy and idiotypic networks: a time to redefine concepts. Clin Exp Immunol 1993;91:193-5.
51. Randen I, Potter KN, Li Y, et al. Complementarity-determining region 2 is implicated in the binding of staphylococcal protein A to human immunoglobulin VHIII variable regions. Eur J Immunol 1993;23:2682-6.
|
Language: | English.
|
Document Type: | Articles.
|
ISSN: | 0022-1899
|
Annotation(s) | |
|
|